Literature DB >> 16807698

The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis.

J K Jackson1, T Higo, W L Hunter, H M Burt.   

Abstract

OBJECTIVE: Curcumin and quercetin are antioxidant molecules with anti-proliferative, anti-inflammatory and immunosuppressive activities. The objective of this study was to investigate the inhibitory activity of these agents using four assays of inflammatory aspects of arthritis.
METHODS: Crystal-induced neutrophil activation was measured by luminol-dependent chemiluminescence. Synoviocyte proliferation was measured by an MTS assay using HIG-82 rabbit synoviocytes in cell culture. Chondrocyte (cultured primary cells) expression of the matrix metalloproteinases collagenase and stromelysin was measured by Northern Blot analysis. Angiogenesis was measured using the chorioallantoic membrane of the chick embryo.
RESULTS: Both agents inhibited neutrophil activation, synoviocyte proliferation and angiogenesis. Curcumin strongly inhibited collagenase and stromelysin expression at micromolar concentrations whereas quercetin had no effect in this assay.
CONCLUSION: These studies suggest that curcumin and to a lesser extent quercetin may offer therapeutic potential for the treatment of crystal-induced arthritis or rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807698     DOI: 10.1007/s00011-006-0067-z

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  41 in total

1.  Quercetin inhibits IL-1β-induced proliferation and production of MMPs, COX-2, and PGE2 by rheumatoid synovial fibroblast.

Authors:  Myung-Soon Sung; Eun-Gyeong Lee; Hyun-Soon Jeon; Han-Jung Chae; Seoung Ju Park; Yong Chul Lee; Wan-Hee Yoo
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

2.  Improvement of bioavailability and anti-inflammatory potential of curcumin in combination with emu oil.

Authors:  Manish Kumar Jeengar; Shweta Shrivastava; Kala Nair; Sreenivasa Reddy Singareddy; Uday Kumar Putcha; M V N Kumar Talluri; V G M Naidu; Ramakrishna Sistla
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

3.  Curcumin synergizes with resveratrol to stimulate the MAPK signaling pathway in human articular chondrocytes in vitro.

Authors:  Mehdi Shakibaei; Ali Mobasheri; Constanze Buhrmann
Journal:  Genes Nutr       Date:  2010-05-25       Impact factor: 5.523

Review 4.  "Spicing up" of the immune system by curcumin.

Authors:  Ganesh Chandra Jagetia; Bharat B Aggarwal
Journal:  J Clin Immunol       Date:  2007-01-09       Impact factor: 8.317

5.  Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment.

Authors:  Charlotta D Mock; Brian C Jordan; Chelliah Selvam
Journal:  RSC Adv       Date:  2015-09-02       Impact factor: 3.361

6.  Dual drug-loaded biodegradable Janus particles for simultaneous co-delivery of hydrophobic and hydrophilic compounds.

Authors:  Jennifer S Winkler; Mayur Barai; Maria S Tomassone
Journal:  Exp Biol Med (Maywood)       Date:  2019-10

Review 7.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

Review 8.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

9.  Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes.

Authors:  M Mathy-Hartert; I Jacquemond-Collet; F Priem; C Sanchez; C Lambert; Y Henrotin
Journal:  Inflamm Res       Date:  2009-07-05       Impact factor: 4.575

10.  p53 contributes to quercetin-induced apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  Peng Xiao; Yingjie Hao; Xu Zhu; Xuejian Wu
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.